Expenditures for the care of HIV-infected patients in rural areas in China's antiretroviral therapy programs
2011

Costs of HIV Treatment in Rural China

Sample size: 276 publication 10 minutes Evidence: moderate

Author Information

Author(s): Zhou Feng, Kominski Gerald F, Qian Han-Zhu, Wang Jiansheng, Duan Song, Guo Zhiwei, Zhao Xinping

Primary Institution: Institute of Pathogen Biology, Chinese Academy of Medical Science

Hypothesis

What are the actual expenditures and factors influencing costs for untreated AIDS patients in rural China after initiating antiretroviral therapy?

Conclusion

The study found that costs for antiretroviral drugs were the largest part of HIV medical expenditures, and starting treatment at higher CD4 cell counts can reduce overall treatment costs.

Supporting Evidence

  • 85% of total expenditure was spent on ARV medications.
  • Patients with lower CD4 counts had higher treatment costs.
  • Initiating HAART at higher CD4 counts can reduce treatment expenses.

Takeaway

This study looked at how much it costs to treat people with HIV in rural China, finding that starting treatment earlier can save money.

Methodology

A retrospective cohort study was conducted, collecting data from medical records and prescriptions at local hospitals.

Potential Biases

Potential bias due to the selection of study sites and the retrospective nature of the data collection.

Limitations

The results may not be applicable to all of China due to regional cost differences and the study's focus on specific provinces.

Participant Demographics

276 patients, average age 39 years, 62% male, 71% married, diverse ethnic backgrounds including Han and Jingpo.

Statistical Information

P-Value

p<0.004

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1741-7015-9-6

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication